Financhill
Back

Keros Therapeutics Quote, Financials, Valuation and Earnings

Keros Therapeutics Price Quote

$60.98
+1.27 (+2.13%)
(Updated: February 22, 2024 at 5:55 PM ET)

Keros Therapeutics Key Stats

Buy
54
Keros Therapeutics (KROS) is a Buy

Day range:
$59.42 - $62.37
52-week range:
$27.02 - $62.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.05%

Volume:
207.6K
Avg. volume:
428.5K
1-year change:
11.38%
Market cap:
$1.8B
Revenue:
$0
EPS:
$-4.95

How Much Does Keros Therapeutics Make?

Data Unavailable

Is Keros Therapeutics Growing As A Company?

Data Unavailable

Keros Therapeutics Stock Price Performance

What Is Keros Therapeutics 52-Week High & Low?

Keros Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Keros Therapeutics?

Is Keros Therapeutics Cash Flow Positive?

  • What Is KROS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$120.5M
  • What Is Keros Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $171.1M
  • What Is Keros Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.3M

Keros Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    KROS return on invested capital is -47.63%
  • What Is Keros Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -43.8%
  • What Is KROS Return On Equity?
    ROE is a measure of profitability and is -47.63%

Keros Therapeutics Earnings Date & Stock Price

Keros Therapeutics Competitors

  • Who Are Keros Therapeutics's Competitors?
    Below is a list of companies who compete with Keros Therapeutics or are related in some way:
    • Arcutis Biotherapeutics Inc (ARQT)
    • Geron Corp (GERN)
    • Pacira BioSciences Inc (PCRX)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Scholar Rock Holding Corp (SRRK)

Keros Therapeutics Dividend Yield

Data Unavailable

Keros Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.38%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 82.30
Upside from Last Price: 37.83%

Major Shareholders

  • How many KROS shares are owned by institutional investors?
    38.2M KROS shares are owned by institutional investors
  • How many KROS shares are owned by insiders?
    372.2K KROS shares are owned by insiders